The guidelines included in this application aim to offer comprehensive and easily understandable information on drug dialyzability. These guidelines have been developed by utilizing a wide range of literature sources. Despite the extensive research, there remains a lack of dialysis pharmacokinetic studies for many drugs, including newly approved medications, investigational agents, and those obtainable in other countries. It is important to note that discrepancies might exist in the available data. Furthermore, the dialysis conditions outlined in published studies may not align with current dialysis practices and technological advancements.
Variables such as the duration of dialysis, blood and dialysate flow rates, types of dialysis membranes, and whether peritoneal dialysis is continuous or intermittent can all influence drug removal rates. The guidelines make a clear distinction between conventional hemodialysis and high permeability (high-flux) hemodialysis where data on such categorizations are accessible. Notably, information on drug dialyzability with continuous renal replacement therapy (CRRT) or plasmapheresis is not provided. For detailed insights on specific drugs, users are encouraged to refer to primary literature sources.
Users are directed to visit www.renalpharmacyconsultants.com for additional background information and explanatory material to aid in interpreting the tabular data provided within the application. The website contains detailed information on factors impacting drug dialyzability and particular considerations like CRRT, plasmapheresis, and substances of abuse. Prior familiarization with these details is essential before utilizing the content of this application. Moreover, the website hosts a table featuring sieving coefficient data from both in vitro and in vivo assessments, which can be instrumental in predicting dosing requirements in CRRT. Another table on the removal of substances of abuse is also available.
To access the application data, users must subscribe to an auto-renewing one-year plan. The subscription will renew automatically unless canceled at any point.
Terms of Service: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
– Áttekintés
Dialysis of Drugs Guide Freeware szoftvere a kategória Otthon & hobbi fejlett mellett Renal Pharmacy Consultants, LLC-ban.
A legutolsó változat-ból Dialysis of Drugs Guide a(z) 1.8.9, 2024. 05. 24. megjelent. Kezdetben volt hozzá, hogy az adatbázisunkban a 2024. 05. 24..
a(z) Dialysis of Drugs Guide a következő operációs rendszereken fut: iOS.
Felhasználók Dialysis of Drugs Guide 3 ki 5 csillagos minősítést adott neki.
Kapcsolódó termékek
2024. 11. 25. | Zoom 6.2.11.50939 |
2024. 11. 25. | TunePat YouTube Music Converter 2.5.2 |
2024. 11. 25. | TunePat YouTube Music Converter for MAC 2.5.3 |
2024. 11. 25. | ChequeSystem Electronic Cheque Writer 8.4.3 |
2024. 11. 25. | YT Downloader 9.11.2 |
az ingyenes UpdateStar-ral.
2024. 11. 21. | US government wants Google to sell the Chrome browser |
2024. 11. 20. | 7-Zip update fixes vulnerability |
2024. 11. 20. | Why use a VPN service in 2025? |
2024. 11. 13. | Adobe October 2024 Patch Day |
2024. 11. 05. | Crowdstrike Strikes Again: Office Crashes, Windows 11 Stalls |
Legutóbbi visszajelzések
App Explorer
Fedezze fel az alkalmazások világát a SweetLabs App Explorer segítségével. |
|
HP System Event Utility
HP rendszeresemény-segédprogram: A rendszeresemények kezelésének egyszerűsítése |
|
utools
Növelje termelékenységét az uTools segítségével! |
|
Canon G2000 series MP Drivers
Hatékony nyomtató-illesztőprogramok a Canon G2000 sorozathoz |
|
Autodesk Featured Apps
Engedje szabadjára kreativitását az Autodesk kiemelt alkalmazásaival! |
|
safeRweb
Védje online adatait a safeRweb segítségével |